Notifications
Clear all
Topic starter
02/06/2026 8:01 am
... The vaccine was developed using CRISPR gene-editing technology to mutate the Leishmania parasite that causes the skin disease.
https://news.osu.edu/phase-1-clinical-trial-set-to-begin-on-first-leishmaniasis-vaccine/